Two Phases of Nitrergic Neuropathy in Streptozotocin-Induced Diabetic Rats
Two Phases of Nitrergic Neuropathy in Streptozotocin-Induced Diabetic Rats Selim Cellek , Neale A. Foxwell and Salvador Moncada From the Wolfson Institute for Biomedical Research, University College London, London, U.K Address correspondence and reprint requests to Dr. Selim Cellek, Wolfson Institut...
Saved in:
Published in | Diabetes (New York, N.Y.) Vol. 52; no. 9; pp. 2353 - 2362 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
Alexandria, VA
American Diabetes Association
01.09.2003
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Two Phases of Nitrergic Neuropathy in Streptozotocin-Induced Diabetic Rats
Selim Cellek ,
Neale A. Foxwell and
Salvador Moncada
From the Wolfson Institute for Biomedical Research, University College London, London, U.K
Address correspondence and reprint requests to Dr. Selim Cellek, Wolfson Institute for Biomedical Research, University College
London, Gower Street, Cruciform Building, London, WC1E 6BT, U.K. E-mail: s.cellek{at}ucl.ac.uk
Abstract
The distinction between metabolic and structural changes occurring in autonomic neurons during diabetes has not been fully
clarified. Here we demonstrate that nitric oxide synthase-containing (nitrergic) neurons innervating the penis and gastric
pylorus of streptozotocin-induced diabetic rats undergo a selective degenerative process in two phases. In the first phase,
nitrergic nerve fibers lose some of their neuronal nitric oxide synthase content and function. In the second phase, nitrergic
degeneration takes place in the cell bodies in the ganglia, leading to complete loss of nitrergic function. The changes in
the first phase are reversible with insulin replacement; however, the neurodegeneration in the second phase is irreversible.
Neurodegeneration is due to apoptotic cell death in the ganglia, which is selective for the nitrergic neurones.
AGE, advanced glycation end product
ChAT, choline acetyl transferase
EFS, electrical field stimulation
eNOS, endothelial nitric oxide synthase
iNOS, inducible nitric oxide synthase
l-NAME, NG-nitro-l-arginine methyl ester
MPG, major pelvic ganglion
NANC, nonadrenergic noncholinergic
NOS, nitric oxide synthase
nNOS, neuronal nitric oxide synthase
ROS, reactive oxygen species
sGC, soluble guanylyl cyclase
SP, substance P
STZ, streptozotocin
TH, tyrosine hydroxylase
TTX, tetrodotoxin
TUNEL, terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling
VAChT, vesicular acetylcholine transporter
VIP, vasoactive intestinal peptide
Footnotes
Accepted May 29, 2003.
Received March 3, 2003.
DIABETES |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0012-1797 1939-327X |
DOI: | 10.2337/diabetes.52.9.2353 |